BioNTech and Pfizer COVID vaccine

With the announcement, Abogen joins Pfizer/BioNTech and Moderna in trialling candidates modified specifically against Omicron

The companies also plan to submit these data to the European Medicines Agency (EMA) and other regulatory agencies around the world…

The agency said the new boosters - a fourth round of shots for most vaccine recipients - of the Pfizer Inc/BioNTech SE and Moderna…

Data is expected in April, the company said in a statement yesterday

In the study, individuals who had received a single COVID vaccine dose were 41 per cent less likely to become infected with…

The researchers at Washington University School of Medicine in the US assessed the antibody response to the Pfizer-BioNTech…

The study, published in The Lancet Regional Health-Americas, assessed the effectiveness of two doses of the Pfizer COVID-19…

The study, sponsored by the vaccine developer, was conducted between 1st January and 7th September last year, before the Omicron…

AstraZeneca is currently the most distributed vaccine by COVAX, according to data from Gavi, the vaccine alliance that co-manages…

The study found that six out of the seven boosters examined enhanced immunity after initial vaccination with Pfizer-BioNTech's…